Fig. 2From: Conversion surgery following gemcitabine plus cisplatin therapy for initially unresectable gallbladder cancer with peritoneal carcinomatosis: a case reportClinical course of treatment after hospitalization and changes in CEA and CA19-9 levels. CEA, carcinoembryonic antigen; CA19-9, carbohydrate antigen 19-9Back to article page